Genomic variability in Zika virus in GBS cases in Colombia

Major clusters of Guillain-Barré Syndrome (GBS) emerged during the Zika virus (ZIKV) outbreaks in the South Pacific and the Americas from 2014 to 2016. The factors contributing to GBS susceptibility in ZIKV infection remain unclear, although considerations of viral variation, patient susceptibility,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2024-11, Vol.19 (11), p.e0313545
Hauptverfasser: Rivera-Franco, Nelson, López-Alvarez, Diana, Castillo, Andrés, Aristizabal, Erica, Puiu, Daniela, Salzberg, Steven L, Pardo, Carlos A, Parra, Beatriz
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 11
container_start_page e0313545
container_title PloS one
container_volume 19
creator Rivera-Franco, Nelson
López-Alvarez, Diana
Castillo, Andrés
Aristizabal, Erica
Puiu, Daniela
Salzberg, Steven L
Pardo, Carlos A
Parra, Beatriz
description Major clusters of Guillain-Barré Syndrome (GBS) emerged during the Zika virus (ZIKV) outbreaks in the South Pacific and the Americas from 2014 to 2016. The factors contributing to GBS susceptibility in ZIKV infection remain unclear, although considerations of viral variation, patient susceptibility, environmental influences, and other potential factors have been hypothesized. Studying the role of viral genetic factors has been challenging due to the low viral load and rapid viral clearance from the blood after the onset of Zika symptoms. The prolonged excretion of ZIKV in urine by the time of GBS onset, when the virus is no longer present in the blood, provides an opportunity to unravel whether specific ZIKV mutations are related to the development of GBS in certain individuals. This study aimed to investigate the association between specific ZIKV genotypes and the development of GBS, taking advantage of a unique collection of ZIKV-positive urine samples obtained from GBS cases and controls during the 2016 ZIKV outbreak in Colombia. Utilizing Oxford-Nanopore technology, we conducted complete genome sequencing of ZIKV in biological samples from 15 patients with GBS associated with ZIKV and 17 with ZIKV infection without neurological complications. ZIKV genotypes in Colombia exhibited distribution across three clades (average bootstrap of 90.9±14.9%), with two clades dominating the landscape. A comparative analysis of ZIKV genomes from GBS and non-neurological complications, alongside 1368 previously reported genomes, revealed no significant distinctions between the two groups. Both genotypes were similarly distributed among observed clades in Colombia. Furthermore, no variations were identified in the amino acid composition of the viral genome between the two groups. Our findings suggest that GBS in ZIKV infection is perhaps associated with patient susceptibility and/or other para- or post-infectious immune-mediated mechanisms rather than with specific ZIKV genome variations.
doi_str_mv 10.1371/journal.pone.0313545
format Article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_3130600143</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A816731574</galeid><doaj_id>oai_doaj_org_article_6a262d36764d44d88244b16a9ee80c55</doaj_id><sourcerecordid>A816731574</sourcerecordid><originalsourceid>FETCH-LOGICAL-c572t-2132817d8b3b07a3ebcd14cebce934ef71ec4a6a176287f433d4ed8d6f82ae123</originalsourceid><addsrcrecordid>eNqNkl9v0zAUxS0EYqPwDRBUQkLw0OJ_cVxe0KigVJo0iQEPvFg3ttN6uHGxk4p9e9w1mxq0B5QHx87vnJt7fRB6TvCUsJK8uwpdbMBPt6GxU8wIK3jxAJ2SGaMTQTF7ePR-gp6kdIVxwaQQj9EJmxWCkJk8Re8Xtgkbp8c7iA4q5117PXbN-Kf7BeOdi13a7xYfL8cakr3ZzIMPm8rBU_SoBp_ss34doe-fP32bf5mcXyyW87PziS5K2k4oYVSS0siKVbgEZittCNd5sTPGbV0SqzkIIKWgsqw5Y4ZbI42oJQVLKBuhlwffrQ9J9W0nlTvGAmOSBSO0PBAmwJXaRreBeK0COHVzEOJKQWyd9lYJoIIaJkrBDedGSsp5RQTMrJVYF0X2-tBX66qNNdo2bQQ_MB1-adxarcJOEVKUhcwjH6E3vUMMvzubWrVxSVvvobGhO_y4pJIymdFX_6D3t9dTK8gduKYOubDem6ozSUTJcmWeqek9VH6MzfebQ1K7fD4QvB0IMtPaP-0KupTU8vLr_7MXP4bs6yN2bcG36xR817rQpCHID6COIaVo67spE6z2Gb-dhtpnXPUZz7IXxzd0J7oNNfsLls7z2Q</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3130600143</pqid></control><display><type>article</type><title>Genomic variability in Zika virus in GBS cases in Colombia</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Public Library of Science (PLoS)</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Rivera-Franco, Nelson ; López-Alvarez, Diana ; Castillo, Andrés ; Aristizabal, Erica ; Puiu, Daniela ; Salzberg, Steven L ; Pardo, Carlos A ; Parra, Beatriz</creator><contributor>Ruiz-Saenz, Julian</contributor><creatorcontrib>Rivera-Franco, Nelson ; López-Alvarez, Diana ; Castillo, Andrés ; Aristizabal, Erica ; Puiu, Daniela ; Salzberg, Steven L ; Pardo, Carlos A ; Parra, Beatriz ; NEAS ; on behalf of NEAS ; Ruiz-Saenz, Julian</creatorcontrib><description>Major clusters of Guillain-Barré Syndrome (GBS) emerged during the Zika virus (ZIKV) outbreaks in the South Pacific and the Americas from 2014 to 2016. The factors contributing to GBS susceptibility in ZIKV infection remain unclear, although considerations of viral variation, patient susceptibility, environmental influences, and other potential factors have been hypothesized. Studying the role of viral genetic factors has been challenging due to the low viral load and rapid viral clearance from the blood after the onset of Zika symptoms. The prolonged excretion of ZIKV in urine by the time of GBS onset, when the virus is no longer present in the blood, provides an opportunity to unravel whether specific ZIKV mutations are related to the development of GBS in certain individuals. This study aimed to investigate the association between specific ZIKV genotypes and the development of GBS, taking advantage of a unique collection of ZIKV-positive urine samples obtained from GBS cases and controls during the 2016 ZIKV outbreak in Colombia. Utilizing Oxford-Nanopore technology, we conducted complete genome sequencing of ZIKV in biological samples from 15 patients with GBS associated with ZIKV and 17 with ZIKV infection without neurological complications. ZIKV genotypes in Colombia exhibited distribution across three clades (average bootstrap of 90.9±14.9%), with two clades dominating the landscape. A comparative analysis of ZIKV genomes from GBS and non-neurological complications, alongside 1368 previously reported genomes, revealed no significant distinctions between the two groups. Both genotypes were similarly distributed among observed clades in Colombia. Furthermore, no variations were identified in the amino acid composition of the viral genome between the two groups. Our findings suggest that GBS in ZIKV infection is perhaps associated with patient susceptibility and/or other para- or post-infectious immune-mediated mechanisms rather than with specific ZIKV genome variations.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0313545</identifier><identifier>PMID: 39561198</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Adult ; Amino acid composition ; Amino acids ; Analysis ; Bacterial infections ; Biological properties ; Biological samples ; Biology and life sciences ; Biotechnology industry ; Blood ; Colombia - epidemiology ; Comparative analysis ; Computer and Information Sciences ; Diagnosis ; Disease Outbreaks ; Disease susceptibility ; DNA sequencing ; Epidemics ; Female ; Gene sequencing ; Genes ; Genetic aspects ; Genetic factors ; Genetic Variation ; Genome, Viral - genetics ; Genomes ; Genomics ; Genotype ; Genotypes ; Guillain-Barre syndrome ; Guillain-Barre Syndrome - epidemiology ; Guillain-Barre Syndrome - virology ; Health aspects ; Humans ; Immune clearance ; Infection ; Infections ; Male ; Maximum likelihood method ; Medical research ; Medicine and Health Sciences ; Medicine, Experimental ; Microcephaly ; Middle Aged ; Mosquitoes ; Neurological complications ; Nucleotide sequencing ; Outbreaks ; People and places ; Phylogenetics ; Phylogeny ; Risk factors ; Urine ; Variation ; Vector-borne diseases ; Viral genetics ; Viruses ; Young Adult ; Zika virus ; Zika Virus - genetics ; Zika Virus - isolation &amp; purification ; Zika Virus Infection - epidemiology ; Zika Virus Infection - urine ; Zika Virus Infection - virology</subject><ispartof>PloS one, 2024-11, Vol.19 (11), p.e0313545</ispartof><rights>Copyright: © 2024 Rivera-Franco et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</rights><rights>COPYRIGHT 2024 Public Library of Science</rights><rights>2024 Rivera-Franco et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2024 Rivera-Franco et al 2024 Rivera-Franco et al</rights><rights>2024 Rivera-Franco et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c572t-2132817d8b3b07a3ebcd14cebce934ef71ec4a6a176287f433d4ed8d6f82ae123</cites><orcidid>0000-0002-8859-7432 ; 0000-0002-5371-7449</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11575819/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11575819/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,724,777,781,861,882,2096,2915,23847,27905,27906,53772,53774,79349,79350</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39561198$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Ruiz-Saenz, Julian</contributor><creatorcontrib>Rivera-Franco, Nelson</creatorcontrib><creatorcontrib>López-Alvarez, Diana</creatorcontrib><creatorcontrib>Castillo, Andrés</creatorcontrib><creatorcontrib>Aristizabal, Erica</creatorcontrib><creatorcontrib>Puiu, Daniela</creatorcontrib><creatorcontrib>Salzberg, Steven L</creatorcontrib><creatorcontrib>Pardo, Carlos A</creatorcontrib><creatorcontrib>Parra, Beatriz</creatorcontrib><creatorcontrib>NEAS</creatorcontrib><creatorcontrib>on behalf of NEAS</creatorcontrib><title>Genomic variability in Zika virus in GBS cases in Colombia</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Major clusters of Guillain-Barré Syndrome (GBS) emerged during the Zika virus (ZIKV) outbreaks in the South Pacific and the Americas from 2014 to 2016. The factors contributing to GBS susceptibility in ZIKV infection remain unclear, although considerations of viral variation, patient susceptibility, environmental influences, and other potential factors have been hypothesized. Studying the role of viral genetic factors has been challenging due to the low viral load and rapid viral clearance from the blood after the onset of Zika symptoms. The prolonged excretion of ZIKV in urine by the time of GBS onset, when the virus is no longer present in the blood, provides an opportunity to unravel whether specific ZIKV mutations are related to the development of GBS in certain individuals. This study aimed to investigate the association between specific ZIKV genotypes and the development of GBS, taking advantage of a unique collection of ZIKV-positive urine samples obtained from GBS cases and controls during the 2016 ZIKV outbreak in Colombia. Utilizing Oxford-Nanopore technology, we conducted complete genome sequencing of ZIKV in biological samples from 15 patients with GBS associated with ZIKV and 17 with ZIKV infection without neurological complications. ZIKV genotypes in Colombia exhibited distribution across three clades (average bootstrap of 90.9±14.9%), with two clades dominating the landscape. A comparative analysis of ZIKV genomes from GBS and non-neurological complications, alongside 1368 previously reported genomes, revealed no significant distinctions between the two groups. Both genotypes were similarly distributed among observed clades in Colombia. Furthermore, no variations were identified in the amino acid composition of the viral genome between the two groups. Our findings suggest that GBS in ZIKV infection is perhaps associated with patient susceptibility and/or other para- or post-infectious immune-mediated mechanisms rather than with specific ZIKV genome variations.</description><subject>Adult</subject><subject>Amino acid composition</subject><subject>Amino acids</subject><subject>Analysis</subject><subject>Bacterial infections</subject><subject>Biological properties</subject><subject>Biological samples</subject><subject>Biology and life sciences</subject><subject>Biotechnology industry</subject><subject>Blood</subject><subject>Colombia - epidemiology</subject><subject>Comparative analysis</subject><subject>Computer and Information Sciences</subject><subject>Diagnosis</subject><subject>Disease Outbreaks</subject><subject>Disease susceptibility</subject><subject>DNA sequencing</subject><subject>Epidemics</subject><subject>Female</subject><subject>Gene sequencing</subject><subject>Genes</subject><subject>Genetic aspects</subject><subject>Genetic factors</subject><subject>Genetic Variation</subject><subject>Genome, Viral - genetics</subject><subject>Genomes</subject><subject>Genomics</subject><subject>Genotype</subject><subject>Genotypes</subject><subject>Guillain-Barre syndrome</subject><subject>Guillain-Barre Syndrome - epidemiology</subject><subject>Guillain-Barre Syndrome - virology</subject><subject>Health aspects</subject><subject>Humans</subject><subject>Immune clearance</subject><subject>Infection</subject><subject>Infections</subject><subject>Male</subject><subject>Maximum likelihood method</subject><subject>Medical research</subject><subject>Medicine and Health Sciences</subject><subject>Medicine, Experimental</subject><subject>Microcephaly</subject><subject>Middle Aged</subject><subject>Mosquitoes</subject><subject>Neurological complications</subject><subject>Nucleotide sequencing</subject><subject>Outbreaks</subject><subject>People and places</subject><subject>Phylogenetics</subject><subject>Phylogeny</subject><subject>Risk factors</subject><subject>Urine</subject><subject>Variation</subject><subject>Vector-borne diseases</subject><subject>Viral genetics</subject><subject>Viruses</subject><subject>Young Adult</subject><subject>Zika virus</subject><subject>Zika Virus - genetics</subject><subject>Zika Virus - isolation &amp; purification</subject><subject>Zika Virus Infection - epidemiology</subject><subject>Zika Virus Infection - urine</subject><subject>Zika Virus Infection - virology</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>DOA</sourceid><recordid>eNqNkl9v0zAUxS0EYqPwDRBUQkLw0OJ_cVxe0KigVJo0iQEPvFg3ttN6uHGxk4p9e9w1mxq0B5QHx87vnJt7fRB6TvCUsJK8uwpdbMBPt6GxU8wIK3jxAJ2SGaMTQTF7ePR-gp6kdIVxwaQQj9EJmxWCkJk8Re8Xtgkbp8c7iA4q5117PXbN-Kf7BeOdi13a7xYfL8cakr3ZzIMPm8rBU_SoBp_ss34doe-fP32bf5mcXyyW87PziS5K2k4oYVSS0siKVbgEZittCNd5sTPGbV0SqzkIIKWgsqw5Y4ZbI42oJQVLKBuhlwffrQ9J9W0nlTvGAmOSBSO0PBAmwJXaRreBeK0COHVzEOJKQWyd9lYJoIIaJkrBDedGSsp5RQTMrJVYF0X2-tBX66qNNdo2bQQ_MB1-adxarcJOEVKUhcwjH6E3vUMMvzubWrVxSVvvobGhO_y4pJIymdFX_6D3t9dTK8gduKYOubDem6ozSUTJcmWeqek9VH6MzfebQ1K7fD4QvB0IMtPaP-0KupTU8vLr_7MXP4bs6yN2bcG36xR817rQpCHID6COIaVo67spE6z2Gb-dhtpnXPUZz7IXxzd0J7oNNfsLls7z2Q</recordid><startdate>20241119</startdate><enddate>20241119</enddate><creator>Rivera-Franco, Nelson</creator><creator>López-Alvarez, Diana</creator><creator>Castillo, Andrés</creator><creator>Aristizabal, Erica</creator><creator>Puiu, Daniela</creator><creator>Salzberg, Steven L</creator><creator>Pardo, Carlos A</creator><creator>Parra, Beatriz</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>COVID</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-8859-7432</orcidid><orcidid>https://orcid.org/0000-0002-5371-7449</orcidid></search><sort><creationdate>20241119</creationdate><title>Genomic variability in Zika virus in GBS cases in Colombia</title><author>Rivera-Franco, Nelson ; López-Alvarez, Diana ; Castillo, Andrés ; Aristizabal, Erica ; Puiu, Daniela ; Salzberg, Steven L ; Pardo, Carlos A ; Parra, Beatriz</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c572t-2132817d8b3b07a3ebcd14cebce934ef71ec4a6a176287f433d4ed8d6f82ae123</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Adult</topic><topic>Amino acid composition</topic><topic>Amino acids</topic><topic>Analysis</topic><topic>Bacterial infections</topic><topic>Biological properties</topic><topic>Biological samples</topic><topic>Biology and life sciences</topic><topic>Biotechnology industry</topic><topic>Blood</topic><topic>Colombia - epidemiology</topic><topic>Comparative analysis</topic><topic>Computer and Information Sciences</topic><topic>Diagnosis</topic><topic>Disease Outbreaks</topic><topic>Disease susceptibility</topic><topic>DNA sequencing</topic><topic>Epidemics</topic><topic>Female</topic><topic>Gene sequencing</topic><topic>Genes</topic><topic>Genetic aspects</topic><topic>Genetic factors</topic><topic>Genetic Variation</topic><topic>Genome, Viral - genetics</topic><topic>Genomes</topic><topic>Genomics</topic><topic>Genotype</topic><topic>Genotypes</topic><topic>Guillain-Barre syndrome</topic><topic>Guillain-Barre Syndrome - epidemiology</topic><topic>Guillain-Barre Syndrome - virology</topic><topic>Health aspects</topic><topic>Humans</topic><topic>Immune clearance</topic><topic>Infection</topic><topic>Infections</topic><topic>Male</topic><topic>Maximum likelihood method</topic><topic>Medical research</topic><topic>Medicine and Health Sciences</topic><topic>Medicine, Experimental</topic><topic>Microcephaly</topic><topic>Middle Aged</topic><topic>Mosquitoes</topic><topic>Neurological complications</topic><topic>Nucleotide sequencing</topic><topic>Outbreaks</topic><topic>People and places</topic><topic>Phylogenetics</topic><topic>Phylogeny</topic><topic>Risk factors</topic><topic>Urine</topic><topic>Variation</topic><topic>Vector-borne diseases</topic><topic>Viral genetics</topic><topic>Viruses</topic><topic>Young Adult</topic><topic>Zika virus</topic><topic>Zika Virus - genetics</topic><topic>Zika Virus - isolation &amp; purification</topic><topic>Zika Virus Infection - epidemiology</topic><topic>Zika Virus Infection - urine</topic><topic>Zika Virus Infection - virology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rivera-Franco, Nelson</creatorcontrib><creatorcontrib>López-Alvarez, Diana</creatorcontrib><creatorcontrib>Castillo, Andrés</creatorcontrib><creatorcontrib>Aristizabal, Erica</creatorcontrib><creatorcontrib>Puiu, Daniela</creatorcontrib><creatorcontrib>Salzberg, Steven L</creatorcontrib><creatorcontrib>Pardo, Carlos A</creatorcontrib><creatorcontrib>Parra, Beatriz</creatorcontrib><creatorcontrib>NEAS</creatorcontrib><creatorcontrib>on behalf of NEAS</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rivera-Franco, Nelson</au><au>López-Alvarez, Diana</au><au>Castillo, Andrés</au><au>Aristizabal, Erica</au><au>Puiu, Daniela</au><au>Salzberg, Steven L</au><au>Pardo, Carlos A</au><au>Parra, Beatriz</au><au>Ruiz-Saenz, Julian</au><aucorp>NEAS</aucorp><aucorp>on behalf of NEAS</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Genomic variability in Zika virus in GBS cases in Colombia</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2024-11-19</date><risdate>2024</risdate><volume>19</volume><issue>11</issue><spage>e0313545</spage><pages>e0313545-</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Major clusters of Guillain-Barré Syndrome (GBS) emerged during the Zika virus (ZIKV) outbreaks in the South Pacific and the Americas from 2014 to 2016. The factors contributing to GBS susceptibility in ZIKV infection remain unclear, although considerations of viral variation, patient susceptibility, environmental influences, and other potential factors have been hypothesized. Studying the role of viral genetic factors has been challenging due to the low viral load and rapid viral clearance from the blood after the onset of Zika symptoms. The prolonged excretion of ZIKV in urine by the time of GBS onset, when the virus is no longer present in the blood, provides an opportunity to unravel whether specific ZIKV mutations are related to the development of GBS in certain individuals. This study aimed to investigate the association between specific ZIKV genotypes and the development of GBS, taking advantage of a unique collection of ZIKV-positive urine samples obtained from GBS cases and controls during the 2016 ZIKV outbreak in Colombia. Utilizing Oxford-Nanopore technology, we conducted complete genome sequencing of ZIKV in biological samples from 15 patients with GBS associated with ZIKV and 17 with ZIKV infection without neurological complications. ZIKV genotypes in Colombia exhibited distribution across three clades (average bootstrap of 90.9±14.9%), with two clades dominating the landscape. A comparative analysis of ZIKV genomes from GBS and non-neurological complications, alongside 1368 previously reported genomes, revealed no significant distinctions between the two groups. Both genotypes were similarly distributed among observed clades in Colombia. Furthermore, no variations were identified in the amino acid composition of the viral genome between the two groups. Our findings suggest that GBS in ZIKV infection is perhaps associated with patient susceptibility and/or other para- or post-infectious immune-mediated mechanisms rather than with specific ZIKV genome variations.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>39561198</pmid><doi>10.1371/journal.pone.0313545</doi><tpages>e0313545</tpages><orcidid>https://orcid.org/0000-0002-8859-7432</orcidid><orcidid>https://orcid.org/0000-0002-5371-7449</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2024-11, Vol.19 (11), p.e0313545
issn 1932-6203
1932-6203
language eng
recordid cdi_plos_journals_3130600143
source MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Public Library of Science (PLoS); PubMed Central; Free Full-Text Journals in Chemistry
subjects Adult
Amino acid composition
Amino acids
Analysis
Bacterial infections
Biological properties
Biological samples
Biology and life sciences
Biotechnology industry
Blood
Colombia - epidemiology
Comparative analysis
Computer and Information Sciences
Diagnosis
Disease Outbreaks
Disease susceptibility
DNA sequencing
Epidemics
Female
Gene sequencing
Genes
Genetic aspects
Genetic factors
Genetic Variation
Genome, Viral - genetics
Genomes
Genomics
Genotype
Genotypes
Guillain-Barre syndrome
Guillain-Barre Syndrome - epidemiology
Guillain-Barre Syndrome - virology
Health aspects
Humans
Immune clearance
Infection
Infections
Male
Maximum likelihood method
Medical research
Medicine and Health Sciences
Medicine, Experimental
Microcephaly
Middle Aged
Mosquitoes
Neurological complications
Nucleotide sequencing
Outbreaks
People and places
Phylogenetics
Phylogeny
Risk factors
Urine
Variation
Vector-borne diseases
Viral genetics
Viruses
Young Adult
Zika virus
Zika Virus - genetics
Zika Virus - isolation & purification
Zika Virus Infection - epidemiology
Zika Virus Infection - urine
Zika Virus Infection - virology
title Genomic variability in Zika virus in GBS cases in Colombia
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T10%3A59%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Genomic%20variability%20in%20Zika%20virus%20in%20GBS%20cases%20in%20Colombia&rft.jtitle=PloS%20one&rft.au=Rivera-Franco,%20Nelson&rft.aucorp=NEAS&rft.date=2024-11-19&rft.volume=19&rft.issue=11&rft.spage=e0313545&rft.pages=e0313545-&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0313545&rft_dat=%3Cgale_plos_%3EA816731574%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3130600143&rft_id=info:pmid/39561198&rft_galeid=A816731574&rft_doaj_id=oai_doaj_org_article_6a262d36764d44d88244b16a9ee80c55&rfr_iscdi=true